Prof. Dr. David Blumenthal

Professur für Biomedical Network Science

Identification of transcriptional regulators using a combined disease module identification and prize-collecting Steiner tree approach (2025) Galindez G, Lopez BA, Blumenthal DB, Kacprowski T Journal article Correction to: The specific DNA methylation landscape in focal cortical dysplasia ILAE type 3D (Acta Neuropathologica Communications, (2023), 11, 1, (129), 10.1186/s40478-023-01618-6) (2024) Wang DD, Katoch M, Jabari S, Blümcke I, Blumenthal DB, Lu DH, Coras R, et al. Journal article, Erratum Network medicine-based epistasis detection in complex diseases: Ready for quantum computing (2024) Hoffmann M, Poschenrieder JM, Incudini M, Baier S, Fritz A, Maier A, Hartung M, et al. Journal article Guiding questions to avoid data leakage in biological machine learning applications (2024) Bernett J, Blumenthal DB, Grimm DG, Haselbeck F, Joeres R, Kalinina OV, List M Journal article Drugst.One - a plug-and-play solution for online systems medicine and network-based drug repurposing (2024) Maier A, Hartung M, Abovsky M, Adamowicz K, Bader GD, Baier S, Blumenthal DB, et al. Journal article NeDRex-Web: An Interactive Web Tool for Drug Repurposing by Exploring Heterogeneous Molecular Networks (2024) Maier A, Rafiei M, Anastasi E, Zolotareva O, Skelton J, Elkjaer ML, Casas AI, et al. Conference contribution, Conference Contribution Emergence of power law distributions in protein-protein interaction networks through study bias (2024) Blumenthal DB, Lucchetta M, Kleist L, Fekete SP, List M, Schaefer MH Journal article, Original article Spatial cell graph analysis reveals skin tissue organization characteristic for cutaneous T cell lymphoma (2024) Sarkar S, Möller A, Hartebrodt A, Erdmann M, Ostalecki C, Baur A, Blumenthal DB Journal article, Original article DysRegNet: Patient-specific and confounder-aware dysregulated network inference towards precision therapeutics (2024) Kersting J, Lazareva O, Louadi Z, Baumbach J, Blumenthal DB, List M Journal article, Original article ZEB1-mediated fibroblast polarization controls inflammation and sensitivity to immunotherapy in colorectal cancer (2024) Menche C, Schuhwerk H, Armstark I, Gupta P, Fuchs K, van Roey R, Mosa MH, et al. Journal article